And it also explains why pairing lifestyle change with GLP-1 drug therapy, for those who choose medication, can produce better results than taking the drugs alone
These products are almost always labeled for research purposes only or not for human use, and there is a very good reason for that
The optimistic scenario assumes: Higher weight-loss efficacy, based on emerging data from trials of AOMs Expanded access to the drug, driving higher uptake assumptions Higher persistency, driven by reduced costs and oral forms of the drug and fewer side effects Lower weight regain after stopping the drug Higher non-weight-loss-related mortality impacts The pessimistic scenario, conversely, considers lower efficacy, lower uptake assumptions, higher and quicker weight regain, and lower non-weight-loss-related mortality impacts
We have to rely on claims by the compounds proponents, which is not ideal
According to the Ozempic SmPC, semaglutide should be discontinued if pancreatitis is suspected and not restarted if pancreatitis is confirmed
If you can't inject, oral semaglutide works but with reduced effectiveness